A TaqMan reverse transcription polymerase chain reaction (RT-PCR) in vitro potency assay for plasmid-based vaccine products. (Q54540559)

31 May 2018

title

A TaqMan reverse transcription polymerase chain reaction (RT-PCR) in vitro potency assay for plasmid-based vaccine products. (English)

1 reference

31 May 2018

author

Jukka Hartikka

7

1 reference

31 May 2018

author name string

Rohit Mahajan

1

1 reference

31 May 2018

Beth Feher

2

1 reference

31 May 2018

Basil Jones

3

1 reference

31 May 2018

Doug Jones

4

1 reference

31 May 2018

Lana Marjerison

5

1 reference

31 May 2018

Mindy Sam

6

1 reference

31 May 2018

Mary Wloch

8

1 reference

31 May 2018

Peggy Lalor

9

1 reference

31 May 2018

David Kaslow

10

1 reference

31 May 2018

Keith Hall

11

1 reference

31 May 2018

Alain Rolland

12

1 reference

31 May 2018

publication date

26 March 2008

1 reference

31 May 2018

published in

Molecular Biotechnology

1 reference

31 May 2018

volume

40

1 reference

31 May 2018

issue

1

1 reference

31 May 2018

page(s)

47-57

1 reference

31 May 2018

A DNA-based vaccine for the prevention of human cytomegalovirus-associated diseases

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12033-008-9058-3

Plasmid vaccines and therapeutics: from design to applications.

21 January 2018

1 reference

12 December 2020

Applications of quantitative PCR in the biosafety and genetic stability assessment of biotechnology products

1 reference

12 December 2020

Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay

1 reference

12 December 2020

Converting an alcohol to an amine in a cationic lipid dramatically alters the co-lipid requirement, cellular transfection activity and the ultrastructure of DNA-cytofectin complexes

1 reference

12 December 2020

A potential disruptive technology in vaccine development: gene-based vaccines and their application to infectious diseases

1 reference

12 December 2020

Real-time PCR for mRNA quantitation

1 reference

12 December 2020

Gene-based vaccines: recent technical and clinical advances

1 reference

12 December 2020

Assessing parallelism prior to determining relative potency

1 reference

12 December 2020

Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine (RotaTeq).

1 reference

12 December 2020

Development of a sensitive and quantitative diagnostic assay for fish nervous necrosis virus based on two-target real-time PCR.

1 reference

12 December 2020

Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses.

1 reference

12 December 2020

A colorimetric assay for viral agents that produce cytopathic effects

1 reference

12 December 2020

Development and evaluation of a real-time RT-PCR assay on the LightCycler for the rapid detection of enterovirus in cerebrospinal fluid specimens

1 reference

12 December 2020

Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency

1 reference

12 December 2020

A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer

1 reference

12 December 2020

In vitro potency assay for yellow fever vaccines: comparison of three vero cell lines sources

1 reference

12 December 2020

Two RT-PCR based assays to detect human metapneumovirus in nasopharyngeal aspirates

1 reference

12 December 2020

Human clinical trials of plasmid DNA vaccines

1 reference

12 December 2020

Nuclear gene delivery: the Trojan horse approach

1 reference

12 December 2020

10.1007/S12033-008-9058-3

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018